Cazzola et al. found that JAK2V617F gene mutations are found in 95% of PV patients and 60–65% of ET or PMF patients, CALR gene mutations are found in 20–25% of ET and PMF patients, and MPL gene mutations are found in 5% of ET and PMF patients [31]. This evidence concerns the gene CALR and essential thrombocythemia.